Bellerophon Therapeutics, Inc.

CIK 1600132 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bellerophon Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 6, 202415-12G0001104659-24-031183
Mar 4, 20248-K0001104659-24-030552
Mar 1, 2024SCHEDULE 13G0002009141-24-000002
Feb 14, 2024SC 13G/A0001214659-24-002862
Feb 14, 2024SC 13G/A0001193125-24-036453
Feb 12, 2024DEFA14A0001104659-24-014026
Feb 12, 2024DEFA14A0001104659-24-014581
Jan 30, 20248-K0001104659-24-007999
Jan 26, 2024SCHEDULE 13G0002009141-24-000001
Jan 26, 2024SC 13G0001013594-24-000074
Jan 22, 20248-K0001104659-24-005554
Jan 10, 20248-K0001104659-24-002968
Jan 3, 2024DEFA14A0001104659-24-000724
Dec 27, 202325-NSE0001354457-23-000994
Dec 12, 20238-K0001104659-23-125371
Nov 21, 20238-K0001104659-23-120348
Nov 14, 202310-Q0001558370-23-019044
Nov 6, 2023DEF 14A0001104659-23-114775
Oct 27, 2023PRE 14A0001104659-23-112046
Oct 18, 2023SC 13D/A0001760460-23-000010
Oct 17, 2023SC 13D/A0001760460-23-000009
Oct 16, 2023S-8 POS0001104659-23-109317
Oct 16, 2023S-8 POS0001104659-23-109316
Oct 16, 2023S-8 POS0001104659-23-109313
Oct 16, 202340001760460-23-000008